Teva intros generic Tykerb
Lapatinib tablets are used to treat breast cancer.
Teva is offering lapatinib tablets, which is the generic of Tykerb.
[Read more: Teva, mAbxience expand partnership for additional oncology biosimilar candidate]
Lapatinib tablets are used with capecitabine to treat people with breast cancer that is advanced or that has spread to other parts of the body (metastatic), and that is HER2-positive (tumors that produce large amounts of a protein called human epidermal growth factor receptor-2), and who have already had certain other breast cancer treatments.